Circadian rhythm-based cancer therapy in randomised clinical trials

Loredana G Marcu,Loredana G. Marcu
DOI: https://doi.org/10.1080/14737140.2023.2298835
2023-12-26
Expert Review of Anticancer Therapy
Abstract:Introduction Since the 2017 Nobel Prize awarded to J. Hall, M. Rosbash and M.W. Young for their discoveries of molecular mechanisms behind the biological clock, circadian rhythm-based therapy, also known as chronotherapy, is receiving more attention in oncology and the number of anatomical sites of interest in this field is increasing. This observation is in line with the clinical evidence provided by trials on head and neck, lung, colorectal and cervical cancers, as well as the presently ongoing chronotherapy trials for breast and brain cancers.
oncology
What problem does this paper attempt to address?